Nkgen Biotech, Inc.
Clinical trials sponsored by Nkgen Biotech, Inc., explained in plain language.
-
Alzheimer's patients continue experimental treatment in Long-Term safety study
Disease control Recruiting nowThis study continues testing an experimental treatment called SNK01 for Alzheimer's disease to check its long-term safety and see if it might help with thinking and memory. It's for 30 people who already completed an earlier study of the same treatment. Participants receive SNK01…
Phase: PHASE2 • Sponsor: NKGen Biotech, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New Alzheimer's treatment enters human testing
Disease control Recruiting nowThis early-stage study aims to test the safety and early signs of effectiveness of an investigational drug called SNK01 for people with moderate Alzheimer's disease. It will involve 36 participants who will receive intravenous infusions every three weeks for up to one year. Resea…
Phase: PHASE1, PHASE2 • Sponsor: NKGen Biotech, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC